Amigas 
AcotBless
Acotiamide 100 mg · Tablet
Prokinetic therapy for functional dyspepsia - improves gastric motility, relieves postprandial fullness, and reduces bloating.
About AcotBless
AcotBless is an oral tablet formulation of Acotiamide 100 mg developed by Amigas Pharma for patients with functional dyspepsia. Functional dyspepsia is a common upper gastrointestinal condition characterised by postprandial fullness, early satiety and upper abdominal discomfort in the absence of structural disease. Acotiamide acts on the enteric nervous system to enhance gastric motility and accommodation, helping restore normal digestion after meals. Each pack contains 10 blister strips of 10 tablets, formulated in a WHO-GMP certified facility with stringent quality control across raw material sourcing, granulation, compression and packaging stages.
Composition
| Ingredient | Strength | Role |
|---|---|---|
| Acotiamide | 100 mg | Prokinetic agent that enhances gastric motility and accommodation through action on the enteric nervous system, addressing meal-related dyspeptic symptoms. |
Product specifications
- Brand name
- AcotBless
- Generic name
- Acotiamide
- Dosage form
- Tablet
- Packaging
- 10 x 10 Tablets
- Category
- Gastrointestinal
- Therapy area
- Gastroenterology
Storage & handling
Store below 25°C in a dry place, protected from direct light and moisture. Keep out of the reach and sight of children. Do not use after the expiry date printed on the pack.
Prescribing information
This product is for use under the supervision of a registered medical practitioner. Please refer to the full prescribing information supplied with the pack insert for indications, dosage, contraindications, warnings and adverse events. Report any adverse events to your physician or to Amigas Pharma.
